Agete Tadewos Hirigo | Medicine and Dentistry | Excellence in Research Award

Posted on by Shen Awards

Mr. Agete Tadewos Hirigo | Medicine and Dentistry | Excellence in Research Award

Hawassa University, Ethiopia

Dr. Agete Tadewos Hirigo is an Assistant Professor at Hawassa University in Ethiopia, specializing in clinical chemistry and medical laboratory sciences. With a robust academic background and extensive research experience, he has significantly contributed to the fields of metabolic disorders, infectious diseases, and clinical diagnostics. Dr. Hirigo has authored over 40 peer-reviewed publications, reflecting his commitment to advancing medical science and improving healthcare outcomes in Ethiopia and beyond.

Professional Profile

Education

Dr. Hirigo’s academic journey began with a Diploma in Medical Laboratory Technology from Addis Ababa University in 2000. He then earned a BSc in Medical Laboratory Technology Sciences from Hawassa University in 2009. In 2012, he completed his MSc in Clinical Laboratory Sciences (Clinical Chemistry) at the University of Gondar. Currently, he is pursuing a PhD in Clinical Nutrition at Addis Ababa University, demonstrating his dedication to continuous learning and specialization in his field.

Professional Experience

Dr. Hirigo’s professional career spans over two decades. He started as a Senior Lab Technologist at Hawassa University Comprehensive Specialized Hospital from 2009 to 2011. He then served as an Expert Clinical Chemist from 2012 to 2015. From 2015 to 2019, he was a Lecturer at the School of Medical Laboratory Sciences, Hawassa University. Since July 2019, he has been serving as an Assistant Professor, where he is involved in lecturing, research, student supervision, and quality assurance in clinical chemistry laboratories.

Research Interests

Dr. Hirigo’s research interests are diverse and impactful. He focuses on metabolic disorders such as dyslipidemia and metabolic syndrome, particularly among HIV-infected and psychiatric patients. His work also encompasses the study of antiretroviral therapy effects, infectious diseases like hepatitis B and C, and public health issues such as hand hygiene practices among schoolchildren. His research aims to address critical health challenges in Ethiopia, contributing to evidence-based interventions and policies.

Research Skills

Dr. Hirigo possesses a comprehensive skill set in clinical laboratory sciences. His expertise includes laboratory diagnostics, clinical chemistry, and the use of statistical tools like SPSS for data analysis. He is proficient in designing and conducting cross-sectional and cohort studies, laboratory quality assurance, and instrument maintenance. His skills are instrumental in both academic research and practical laboratory settings, ensuring high standards of laboratory services and research outputs.

Awards and Honors

While specific awards and honors are not detailed in the available information, Dr. Hirigo’s extensive publication record and academic positions indicate recognition in his field. His involvement in significant research projects and collaborations with other institutions reflect his esteemed status in the academic and medical communities.

Conclusion

Dr. Agete Tadewos Hirigo exemplifies the qualities of a dedicated researcher and educator. His extensive experience, diverse research interests, and commitment to improving healthcare through science make him a valuable asset to the medical community. His work not only advances scientific knowledge but also has practical implications for public health in Ethiopia. Dr. Hirigo’s ongoing contributions continue to inspire and influence the field of clinical laboratory sciences.

Publications Top Notes

📘 1. Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation
Authors: SJ Connolly, G Karthikeyan, M Ntsekhe, A Haileamlak, A El Sayed, …
Journal: New England Journal of Medicine, 387(11), 978–988 (2022)
Citations: 200
🔬 Major randomized trial comparing rivaroxaban and vitamin K antagonists in RHD-AF.

📘 2. Hyperuricemia and Metabolic Syndrome in Type 2 Diabetes Mellitus Patients at Hawassa University
Authors: SB Woyesa, AT Hirigo, TB Wube
Journal: BMC Endocrine Disorders (2017)
Citations: 96
🧪 Correlation study of uric acid levels and metabolic syndrome in diabetic patients.

📘 3. Prevalence of Dyslipidemia Among HIV-Infected Patients Using First-Line HAART
Authors: A Tadewos, Z Addis, H Ambachew, S Banerjee
Journal: AIDS Research and Therapy (2012)
Citations: 91
🩺 Comparative cross-sectional analysis in Southern Ethiopia.

📘 4. Burden of Metabolic Syndrome Among HIV-Infected Patients in Southern Ethiopia
Authors: DY Tesfaye, S Kinde, G Medhin, YC Megerssa, A Tadewos, E Tadesse, …
Journal: Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 8(2), 102–107 (2014)
Citations: 84
🧬 Assessment of metabolic complications among PLHIV on ART.

📘 5. Hepatitis B Virus Among Pregnant Women in Yirgalem Hospital, Ethiopia
Authors: A Amsalu, G Ferede, S Eshetie, A Tadewos, D Assegu
Journal: Journal of Pregnancy (2018), Article ID: 8435910
Citations: 78
👶 Implication of HBV screening for preventing mother-to-child transmission.

📘 6. The INVICTUS Rheumatic Heart Disease Research Program
Authors: G Karthikeyan, SJ Connolly, M Ntsekhe, A Benz, S Rangarajan, G Lewis, …
Journal: American Heart Journal, 225, 69–77 (2020)
Citations: 52
🫀 Study design for comparing rivaroxaban vs. VKA in RHD.

📘 7. Gender Influence in Metabolic Syndrome Among PLHIV on ART
Authors: AT Hirigo, DY Tesfaye
Journal: BMC Research Notes (2016)
Citations: 45
📊 Exploration of sex-based differences in ART-related metabolic issues.

📘 8. Length of Stay in Emergency Departments in Southern Ethiopia
Authors: GH Alemu, KG Negari, KM Rodamo, AT Hirigo
Journal: BMC Research Notes (2019)
Citations: 43
🏥 Study of variables influencing emergency department stay duration.

📘 9. Hand Washing Practices Among Primary Schoolchildren in Yirgalem
Authors: D Eshetu, T Kifle, AT Hirigo
Journal: Journal of Multidisciplinary Healthcare (2020), 759–768
Citations: 36
🧼 KAP study on hygiene practices among schoolchildren.

📘 10. Coinfections with Hepatitis B, C, and Syphilis Among HIV Patients
Authors: T Shimelis, Y Tassachew, A Tadewos, MW Hordofa, A Amsalu, …
Journal: HIV/AIDS – Research and Palliative Care
Citations: 33
⚕️ Cross-sectional data on coinfection rates in PLHIV.

 

Mohamed Nasreldin | Medicine and Dentistry | Excellence in Research Award

Posted on by Shen Awards

Assist. Prof. Dr. Mohamed Nasreldin | Medicine and Dentistry | Excellence in Research Award

Consultant Nephrologist from Imam Abdulrahman Bin Faisal, Saudi Arabia

Dr. Mohamed Ahmed Nasreldin is an American consultant internist and nephrologist currently serving as Assistant Professor at King Fahad Hospital of the University (KFHU), Dammam, Saudi Arabia. With over 16 years of clinical experience, he has demonstrated exceptional competence in both internal medicine and nephrology, managing complex cases with compassion, precision, and interdisciplinary collaboration. Dr. Nasreldin holds a rich academic background complemented by international qualifications and fellowships, including the prestigious Fellow of the American Society of Nephrology (FASN). His work spans clinical care, teaching, and research, particularly in dialysis, kidney transplantation, and interventional nephrology. A committed educator, he has contributed significantly to medical education by tutoring nephrology fellows and mentoring residents and medical students. His fluency in Arabic, English, and Russian enhances his ability to connect across cultures and deliver impactful education and care. Dr. Nasreldin has received several awards and certificates of appreciation for his excellence in research presentations, academic contributions, and leadership in clinical practice. With a strong foundation in research and clinical trials, he has authored multiple peer-reviewed publications and continues to contribute to national and international nephrology forums. His career reflects a balanced dedication to patient care, clinical innovation, and academic leadership.

Professional Profile

Education

Dr. Mohamed Ahmed Nasreldin has pursued a comprehensive and international academic journey in medicine and nephrology. He holds a PhD in Clinical Nephrology (2016–2019) from UCN, USA, and a Clinical MD in Internal Medicine from Odessa State Medical University, Ukraine (2005–2009). He also earned an MBBS with honors in Medicine and Surgery from the same institution. His postgraduate education includes an MSc in Renal Medicine and a Postgraduate Diploma in Renal Medicine from the University of South Wales, UK. Dr. Nasreldin’s credentials also include the European Specialty Examination in Nephrology (ESENeph), jointly administered by the UEMS and the Royal College of Physicians, UK, along with a Fellowship from the American Society of Nephrology (FASN) awarded in 2019. His education is further supported by numerous certifications from globally recognized institutions, such as Johns Hopkins University (clinical research), the University of Leiden (kidney and pancreas transplantation), and the Royal College of Physicians, UK (renal medicine). In addition, he has completed specialized training in kidney pathology, gout management, and ADPKD treatment. This robust academic foundation not only underpins his clinical and research proficiency but also reflects his commitment to lifelong learning and evidence-based practice.

Professional Experience

With 16 years of experience in internal medicine and nephrology, Dr. Mohamed Nasreldin has established himself as a highly competent and dedicated clinician. He began his medical career with a residency program at Odessa State Medical University, where he gained extensive exposure to various subspecialties. Since 2009, he has been an integral part of the internal medicine department at King Fahad Hospital of the University (KFHU), Saudi Arabia. In this role, he manages both inpatient and outpatient care, including hemodialysis and peritoneal dialysis patients, and is actively involved in hospital consultations and on-call duties. Dr. Nasreldin’s clinical expertise covers a broad spectrum, from acute kidney injury and chronic kidney disease to renal transplantation and interventional nephrology. In addition to his clinical responsibilities, he plays a pivotal role in medical education and training. He tutors nephrology fellows, mentors residents, and delivers lectures to undergraduate and postgraduate students. His leadership in clinical care, education, and patient safety has been consistently recognized by peers and institutional authorities. Known for his problem-solving abilities under pressure, team collaboration, and organizational skills, Dr. Nasreldin continues to contribute significantly to both patient outcomes and the development of future nephrologists.

Research Interests

Dr. Mohamed Nasreldin’s research interests lie primarily in clinical nephrology, with a strong focus on dialysis modalities, renal transplantation, and interventional nephrology. He is particularly passionate about improving outcomes for patients on peritoneal dialysis and exploring patient-centered decision-making processes in renal care. His doctoral research examined the use of prophylactic antibiotics in end-stage renal disease (ESRD) patients undergoing colonoscopy while on automated peritoneal dialysis—a prospective randomized controlled trial that reflects his commitment to optimizing clinical protocols through evidence-based research. Dr. Nasreldin is also interested in transplant nephrology, including the management of acute and chronic allograft nephropathy, and the development of new catheter insertion techniques. His research extends to diabetes-related kidney disease, endothelial dysfunction in ischemic heart disease, and innovative strategies in nephrology education and practice. He has actively participated in clinical trials, presented findings at national and international conferences, and published research aimed at improving therapeutic outcomes in nephrology. As a mentor, he supervises clinical research for residents and fellows, fostering an academic environment that values inquiry and innovation. His dedication to research enhances his clinical practice, ensuring that patients benefit from the most current and effective medical interventions.

Research Skills

Dr. Nasreldin possesses a well-rounded set of research skills developed over more than a decade of conducting clinical investigations in internal medicine and nephrology. He is experienced in the design, monitoring, and execution of clinical trials, particularly randomized controlled studies that assess new interventions in renal care. His skills encompass the formulation of research hypotheses, patient recruitment and consent, data collection and analysis, and the interpretation of clinical findings for publication and presentation. Dr. Nasreldin is also proficient in guiding research as a supervisor and mentor, especially for nephrology fellows and internal medicine residents. His methodological strengths include statistical analysis, critical appraisal of the literature, and integration of research into clinical practice. Additionally, his ability to present research findings at scientific forums and publish in peer-reviewed journals underscores his communication and academic writing abilities. He is trained in research ethics and regulatory compliance, having completed a clinical research certificate from Johns Hopkins University. His involvement in various educational workshops and clinical symposiums enhances his collaborative research experience. These research skills have enabled him to contribute significantly to medical knowledge in nephrology, while also improving clinical decision-making and patient outcomes.

Awards and Honors

Dr. Mohamed Nasreldin has been recognized multiple times for his contributions to nephrology through awards and certificates of appreciation, reflecting both his clinical excellence and academic achievements. Notably, he received a Certificate of Appreciation at the First Gulf Peritoneal Dialysis Forum in Oman (2024) and won first place for poster presentation at the ISN-EMAN Update Congress in Nephrology, Dubai (2017). His oral presentation on acute kidney injury at the Saudi International Congress of Nephrology and Transplantation (2018) earned commendation, as did his role as a speaker at the International Conference of Diabetes and Its Complications in Baltimore (2017). He was honored by the nephrology division at King Fahad Hospital of the University for upholding high standards of care aligned with JCI requirements. Additionally, his participation in public awareness events, such as World Kidney Day, and academic initiatives like the 3rd Annual Research Day at King Saud University (2012), further illustrate his professional commitment. These accolades emphasize his role as a thought leader in nephrology, combining research, clinical practice, and public engagement. The consistent recognition from national and international platforms affirms Dr. Nasreldin’s impact on advancing kidney health and medical education.

Conclusion

Dr. Mohamed Ahmed Nasreldin stands out as a distinguished clinician, educator, and researcher in the field of nephrology, making him a strong candidate for the Excellence in Research Award. His extensive academic background, including a PhD in clinical nephrology and fellowship with the American Society of Nephrology, lays the foundation for his clinical acumen and research productivity. With over 16 years of experience, Dr. Nasreldin has shown exemplary commitment to improving patient outcomes, mentoring the next generation of physicians, and contributing to the scientific community. His research spans dialysis innovations, kidney transplantation, and interventional nephrology, all grounded in real-world clinical challenges. While his scholarly output could benefit from more high-impact journal publications and international collaborations, his existing contributions and active engagement in medical forums are noteworthy. Dr. Nasreldin’s work aligns closely with the criteria for the Excellence in Research Award—particularly through his original investigations, teaching impact, and patient-centered clinical innovations. His trajectory reflects a blend of practical application and academic inquiry, reinforcing his value to the nephrology community. Continued institutional support and broader research dissemination could further enhance his profile, making him not only a deserving recipient but also a future leader in academic nephrology.

Publications Top Notes

  1. An update on sickle cell nephropathy
    Author: A. Alhwiesh
    Journal: Saudi Journal of Kidney Diseases and Transplantation, 25(2), 249–265
    Year: 2014
    Citations: 54

  2. The use of SGLT2 inhibitors in peritoneal dialysis patients: a shade of light on dapagliflozin
    Authors: A.K. Alhwiesh, I.S. Abdul-Rahman, M.A. Nasreldin, A.M. Mohammed, …
    Journal: Archives of Nephrology and Urology, 5(1), 1–8
    Year: 2022
    Citations: 15

  3. Pregnancy in peritoneal dialysis and an infant with a ventricular septal defect
    Author: A. Alhwiesh
    Journal: Saudi Journal of Kidney Diseases and Transplantation, 26(1), 111–114
    Year: 2015
    Citations: 8

  4. A nephrologist dream of peritoneal dialysis catheter with zero migration: a multicenter prospective study
    Authors: A.K. Al‐Hwiesh, I.S. Abdul‐Rahman, J.C. Divino‐Filho, M.A. Nasreldin, …
    Journal: Therapeutic Apheresis and Dialysis, 28(1), 89–95
    Year: 2024
    Citations: 5

  5. A novel three cuff peritoneal dialysis catheter with low entry technique: three years single center experience
    Authors: A. Al-Hwiesh, I. Abdul-Rahman, N. Al-Audah, A. Noor, M. Nasreldin
    Journal: Urol Nephrol Open Access J, 4(5), 150–156
    Year: 2017
    Citations: 5

  6. The problem of pulmonary arterial hypertension in end-stage renal disease: can peritoneal dialysis be the solution
    Authors: A.K. Alhwiesh, I.S. Abdul-Rahman, A. Alshehri, A. Alhwiesh, M. Elnokeety, …
    Journal: BMC Nephrology, 23(1), 386
    Year: 2022
    Citations: 4

  7. Is percutaneous gastrostomy tube insertion contraindicated in adult peritoneal dialysis patients? A single-centre experience of three successful cases: it is time to revisit
    Authors: A. Alhwiesh, L. Alayoobi, H.A. Aljenaidi, K.M. Alshehabi, I. Abokaker Alghnimi, …
    Journal: The International Journal of Artificial Organs, 45(4), 438–441
    Year: 2022
    Citations: 2

  8. THE SAUDI PERITONEAL DIALYSIS CATHETER: MODIFIED CATHETER AND NEW TECHNIQUE: FAREWELL TO CATHETER MIGRATION
    Authors: A. Alhwiesh, M. Nasreldin
    Journal: Nephrology Dialysis Transplantation, 31
    Year: 2016
    Citations: 2

  9. The influence of increased peritoneal membrane surface area on dialysis adequacy
    Authors: A. Alhwiesh, S. Esam, I. Saeed, M. Ahmmed, F. Almohana
    Journal: Saudi Journal of Kidney Diseases and Transplantation, 22(4), 717–722
    Year: 2011
    Citations: 2

Fei Liu | Medicine and Dentistry | Young Scientist Award

Posted on by Shen Awards

Dr. Fei Liu | Medicine and Dentistry | Young Scientist Award

FeiDr. Fei Liu is a dedicated and emerging researcher affiliated with The Affiliated Hospital of Traditional Chinese Medicine, Southwest Medical University, China. His academic background is rooted in integrated traditional Chinese and Western medicine, with a research specialization in orthopedics. Dr. Liu has distinguished himself through his contributions to multiple research projects investigating the mechanisms of traditional Chinese medicine compounds and their therapeutic impact on orthopedic conditions. He is particularly focused on the pharmacological action of herbal formulas such as Duhuo Jisheng Tang, and their influence on pathways related to inflammation, apoptosis, and cellular metabolism. His scientific rigor is evident in his publication record, which includes six SCI-indexed journal articles (two as first author), and his involvement in several funded research grants at the provincial and municipal levels. Additionally, Dr. Liu holds a utility patent for an orthopedic surgical instrument, showcasing his commitment to clinical innovation. With a reputation for resilience, strong clinical foundations, and growing independent research capabilities, Dr. Liu is poised to make significant contributions to integrative medicine. Though early in his career, he has already demonstrated a promising trajectory, making him a strong candidate for emerging researcher recognition and a future contender for high-level scientific awards.

Professional Profile

Education

Dr. Fei Liu has pursued a comprehensive academic path in integrative medicine. He earned his undergraduate degree in Clinical Medicine of Integrated Traditional Chinese and Western Medicine from Hebei University of Chinese Medicine. This program laid a strong foundation in both conventional medical sciences and traditional Chinese therapeutic practices. Building upon this dual-focus education, he continued his studies at Southwest Medical University, where he undertook postgraduate training specializing in orthopedics within the same integrated clinical medicine discipline. His graduate research has centered on understanding the therapeutic mechanisms and efficacy of traditional herbal formulas used in orthopedic disorders. Dr. Liu’s educational experiences have provided him with a rare and valuable interdisciplinary skill set, enabling him to explore the complex biological interactions between traditional herbal compounds and modern biomedical systems. As a graduate student, he not only excelled academically—earning multiple prestigious scholarships—but also contributed actively to the academic community, serving as a student party committee member and engaging in various academic assistance roles. These educational milestones have shaped Dr. Liu into a well-rounded medical scientist with the tools to bridge traditional and modern medical practices effectively.

Professional Experience

Dr. Fei Liu’s professional journey has been primarily rooted in research and clinical training within the setting of Southwest Medical University and its affiliated hospital. During his postgraduate studies, he played significant roles in multiple ongoing research projects funded by the Sichuan Provincial Science and Technology Department, the Luzhou municipal government, and other institutional partnerships. He served as a second or third principal researcher on several studies investigating the pharmacological mechanisms of Duhuo Jisheng Tang and other herbal compounds in treating musculoskeletal disorders, particularly intervertebral disc degeneration. His work has involved both clinical observation and experimental design, contributing to tasks such as laboratory assay development, animal model experimentation, molecular analysis, and data interpretation. In parallel with his research activities, Dr. Liu has been involved in routine clinical work, managing patient admissions and performing basic surgical procedures such as internal fixation removals. His practical experience complements his scientific training, allowing him to integrate clinical insight with research innovation. Furthermore, he has actively participated in academic and administrative duties, serving within the student branch of the Party Committee and taking part in academic assistance programs. This balance of clinical proficiency and research engagement highlights his growing capacity as a clinician-scientist.

Research Interests

Dr. Fei Liu’s research interests lie at the intersection of traditional Chinese medicine (TCM) and modern biomedical science, with a particular focus on orthopedic applications. He is especially passionate about elucidating the pharmacological and molecular mechanisms underlying traditional herbal formulas, such as Duhuo Jisheng Tang, in the treatment of degenerative musculoskeletal conditions like intervertebral disc degeneration and osteoporosis. His projects have explored how these formulas influence biological pathways such as the JNK/P38MAPK signaling cascade, apoptosis (pyroptosis), glycolysis, and extracellular matrix degradation. Beyond musculoskeletal disorders, Dr. Liu has also contributed to interdisciplinary studies examining the immunological connections between COVID-19 and osteoporosis, and how m6A methylation affects prognosis and immunotherapy response in hepatocellular carcinoma. His holistic research approach integrates bioinformatics, in vivo and in vitro experimentation, and clinical data analysis. Dr. Liu is particularly interested in the potential of TCM to provide alternative therapeutic pathways with fewer side effects than synthetic drugs, especially when guided by modern research tools. His work contributes to the evolving field of integrative medicine, aiming to validate traditional knowledge using contemporary scientific methods and to promote evidence-based use of herbal treatments in modern clinical settings.

Research Skills

Dr. Fei Liu has developed a robust portfolio of research skills, well-suited to translational and interdisciplinary biomedical research. He possesses hands-on expertise in molecular biology techniques such as Western blotting, PCR, immunohistochemistry, and ELISA, which he has applied to study cellular signaling pathways in degenerative disc disease and related orthopedic conditions. In his various research projects, he has been actively involved in experimental design, animal modeling, data collection, statistical analysis, and manuscript preparation. Dr. Liu is also skilled in the use of bioinformatics tools for gene expression profiling and pathway analysis, which has allowed him to examine complex interactions between inflammation, immune response, and cellular metabolism. Additionally, he is familiar with biomechanical modeling, demonstrated by his collaborative work on lumbar spine simulations. His competence extends to academic writing, with several SCI-indexed journal publications, and to intellectual property development, as evidenced by his patent for a novel orthopedic surgical device. These combined skills reflect a balance of laboratory precision, analytical capability, and creative innovation. His ability to manage multiple research tasks while contributing meaningfully to both clinical and academic settings illustrates a strong foundation for continued scientific growth.

Awards and Honors

Throughout his academic career, Dr. Fei Liu has received several honors and recognitions that underscore his excellence in research and academic performance. He was awarded the National Second-Class Academic Scholarship for the 2020–2021 academic year and subsequently received the National First-Class Academic Scholarship for 2021–2022, highlighting his consistent academic distinction. In addition, he was honored with the “Kangzhe” Scholarship, a prestigious recognition of research potential in medical innovation. Dr. Liu has also been named an Outstanding Graduate Student of the 2020 cohort at his university, a distinction awarded to students demonstrating exceptional contributions in both research and leadership. His early commitment to scholarly excellence is further reflected in his participation as a student party committee member and his contributions to academic assistance initiatives. These accolades are not only a reflection of his academic abilities but also of his leadership qualities, dedication, and strong work ethic. They serve as indicators of his upward trajectory as a medical researcher and clinician. These honors reinforce his reputation as a promising young scholar, capable of making meaningful contributions to the field of integrative and orthopedic medicine.

Conclusion

In conclusion, Dr. Fei Liu exemplifies the qualities of a promising clinician-scientist whose work bridges traditional Chinese medicine and contemporary biomedical science. With a solid academic foundation, diverse professional experience, and a focused research agenda, he has contributed meaningfully to both experimental and translational studies. His involvement in several major research projects and his growing publication record demonstrate his potential for independent research leadership. Dr. Liu’s work not only advances understanding in the field of orthopedics but also enhances the scientific credibility of traditional medicine through rigorous investigation. He has already earned a patent, multiple scholarships, and recognitions that reflect his dedication and innovation. Although still in the early stages of his research career, he has established a strong foundation for future contributions at the national and international levels. With continued mentorship, expanded collaboration, and increased leadership in principal investigator roles, Dr. Liu is well-positioned to evolve into a leading figure in integrative medical research. His achievements to date make him a strong candidate for recognition in emerging researcher categories and a future contender for more senior scientific awards as his academic and professional journey progresses.

Publications Top Notes

Ahmed Maged | Health Professions | Best Researcher Award

Posted on by Shen Awards

Prof. Dr. Ahmed Maged | Health Professions | Best Researcher Award

Professor at Faculty of medicine, Egypt

Professor Ahmed Maged is a distinguished academic specializing in obstetrics and gynecology. He holds the position of Professor at Cairo University’s Kasr Alainy Faculty of Medicine, where he has been a faculty member since January 2012. His extensive research portfolio includes over 79 publications, with a focus on systematic reviews and meta-analyses in women’s health. Notably, his recent work has addressed critical topics such as postpartum hemorrhage prevention and the use of misoprostol in gynecological procedures. Beyond his research, Professor Maged contributes to the academic community as an associate editor for Springer Nature and serves as a reviewer for the Supreme Council of Universities. His dedication to advancing medical knowledge and education underscores his significant role in the field of obstetrics and gynecology.

Professional Profile

Education:

Professor Maged completed his medical education at Cairo University’s Kasr Alainy Faculty of Medicine, earning his MD in 1997. He has since advanced his academic career, achieving the rank of Professor in Obstetrics and Gynecology by 2016. His educational journey reflects a commitment to excellence in medical education and a dedication to the field of obstetrics and gynecology.

Professional Experience:

Since January 2012, Professor Maged has been serving as a Professor of Obstetrics and Gynecology at Cairo University’s Kasr Alainy Faculty of Medicine. In this role, he has been instrumental in educating and mentoring medical students and residents, contributing to the advancement of medical knowledge and practice. His professional experience is further enriched by his involvement in various academic committees and his role as a reviewer for the Supreme Council of Universities, reflecting his active engagement in the academic community.

Research Interests:

Professor Maged’s research interests are centered on women’s health, with a particular focus on obstetrics and gynecology. He has conducted extensive studies on postpartum hemorrhage prevention, the use of misoprostol in gynecological procedures, and the impact of laser acupuncture on metabolic syndrome in obese postmenopausal women. His work aims to improve clinical practices and patient outcomes in these areas.

Research Skills:

Professor Maged possesses advanced research skills, including systematic reviews and meta-analyses, which have been pivotal in synthesizing existing literature and providing evidence-based recommendations in obstetrics and gynecology. His ability to critically evaluate and integrate research findings demonstrates a high level of expertise in research methodology and data analysis.

Awards and Honors:

While specific awards and honors are not detailed in the provided information, Professor Maged’s significant contributions to research and education in obstetrics and gynecology are evident through his extensive publication record and leadership roles in academic committees. His recognition as an associate editor for Springer Nature and as a reviewer for the Supreme Council of Universities highlights his esteemed position in the academic community.

Conclusion:     

Professor Ahmed Maged’s dedication to the field of obstetrics and gynecology is evident through his extensive research, educational contributions, and active involvement in the academic community. His work has significantly advanced understanding and clinical practices in women’s health. His commitment to excellence in research and education underscores his esteemed position in the medical community.

Publications Top Notes

  1. Expression of Concern: Carbetocin versus oxytocin in the management of atonic postpartum hemorrhage (PPH) after vaginal delivery: a randomized controlled trial

    • Authors: A.M. Mohamed Maged, Ahmed Mohamed, A.G.M.A. Hassan, Abdel Gany M.A., N.A.A. Shehata, Nesreen A.A.
    • Year: 2025

  2. A systematic review and meta-analysis of randomized trials comparing carbetocin to oxytocin in prevention of postpartum hemorrhage after cesarean delivery in low-risk women

    • Authors: A.M. Mohamed Maged, Ahmed Mohamed, N.A. El-Goly, Nour A., D. Turki, Doaa, N. Bassiouny, Nehal, N.M. El-Demiry, Nihal Mostafa
    • Year: 2025

  3. The value of misoprostol administration before intrauterine contraceptive device insertion: a systematic review and meta-analysis

    • Authors: A.M. Mohamed Maged, Ahmed Mohamed, N.A. El-Goly, Nour A., N. Bassiouny, Nehal, N.M. El-Demiry, Nihal Mostafa, S. AbdelAziz, Suzi
    • Year: 2024

  4. The use of misoprostol before hysteroscopy in nulliparous women: a systematic review and meta-analysis of randomized controlled trials

    • Authors: N.M. Salah, Noha M., A.M. Mohamed Maged, Ahmed Mohamed, S.I. Mahmoud, Safaa Ibrahim, S. AbdelAziz, Suzi, W.S. Ragab, Wael Samir
    • Year: 2024
    • Citations: 0

  5. The effects of laser acupuncture on metabolic syndrome in obese postmenopausal women: a randomized controlled study

    • Authors: W.M. Kamal, Wafaa Mohammad, A.M. Mohamed Maged, Ahmed Mohamed, S. AbdelAziz, Suzi, S.I. Mahmoud, Safaa Ibrahim, R.A. Mohsen, Reham A.
    • Year: 2024

  6. Impact of treatment interventions of endometriomas prior to in vitro fertilization: a systematic review and meta-analysis

    • Authors: M.A. Katta, Maha Ali, A.M. Mohamed Maged, Ahmed Mohamed, A.I. Ogila, Asmaa I., W.S. Ragab, Wael Samir
    • Year: 2024

  7. The value of intraovarian autologous platelet-rich plasma in women with poor ovarian reserve or ovarian insufficiency: a systematic review and meta-analysis

    • Authors: A.M. Mohamed Maged, Ahmed Mohamed, R.A. Mohsen, Reham A., N.M. Salah, Noha M., W.S. Ragab, Wael Samir
    • Year: 2024
    • Citations: 3

  8. Erratum to: Maternal serum homocysteine and uterine artery Doppler as predictors of preeclampsia and poor placentation

    • Authors: A.M. Mohamed Maged, Ahmed Mohamed, H. Saad, Hany, H. Meshaal, Hadeer, W.S. Deeb, Wesam Sayed, M.A. Katta, Maha Ali
    • Year: 2024

  9. RETRACTED ARTICLE: A randomized controlled study of the effect of hyoscine butylbromide on duration of labor in primigravida women with prolonged labor

    • Authors: A.M. Mohamed Maged, Ahmed Mohamed, E.H. Sorour, Ehab H., M.M. ElSadek, Mostafa M., S.M. Hassan, Sarah Mohamed, A.Y. Shoab, Amira Y.
    • Year: 2024

 

Yvonne Botma | Health Professions | Best Researcher Award

Posted on by Shen Awards

Prof. Yvonne Botma | Health Professions | Best Researcher Award

Researcher, University of the Free State, South Africa

Prof. Yvonne Botma is an Emeritus Professor of Nursing at the University of the Free State, South Africa, with a career spanning over three decades in nursing education. A recognized expert in curriculum development, she has consulted widely across Africa, shaping nursing education programmes to meet international standards. Her work has been pivotal in advancing competency-based training for nurses, particularly in HIV/AIDS and TB care. Prof. Botma’s academic and professional achievements have made her a leader in nursing education, both in South Africa and beyond.

Profile

Scopus Profile

Tu Thai Bao Nguyen | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Mr. Tu Thai Bao Nguyen | Medicine and Dentistry | Best Researcher Award

Ph.D. Student at Taipei Medical University, Taiwan.

Bao Tu Thai Nguyen is a Ph.D. student in the International Graduate Program in Medicine at Taipei Medical University, Taiwan, under the supervision of Assistant Professor Yu-Pin Chen. He also serves as a lecturer in the Department of Orthopedics at Can Tho University of Medicine and Pharmacy, Vietnam, and as an attending physician in the Department of Orthopedics and Neurosurgery at the university’s hospital. Bao Tu holds a Bachelor of Medicine and has contributed extensively to orthopedic research, with publications in esteemed journals like World Neurosurgery and EFORT Open Reviews. His work includes meta-analyses on topics such as anterior cervical discectomy, hip fracture mortality, and the impact of smoking on surgical outcomes. Bao Tu has presented at international conferences, including the European Federation of National Societies of Orthopaedics and Traumatology and the Japanese Orthopaedic Association. His research focuses on orthopedic surgery outcomes, biometrics, and predictive modeling in clinical settings.

Profile:

Education

Bao Tu Thai Nguyen is currently pursuing a Ph.D. in Medicine at the International Graduate Program in Medicine, Taipei Medical University, Taiwan, under the guidance of Assistant Professor Yu-Pin Chen. He began his doctoral studies in September 2022, focusing on advancing his expertise in the field of orthopedic surgery and neurosurgery. Prior to his Ph.D., Nguyen earned his Bachelor of Medicine from Can Tho University of Medicine and Pharmacy, Vietnam, where he completed his studies between September 2013 and July 2019. His strong foundation in medical education has equipped him with extensive clinical knowledge, particularly in orthopedics. Throughout his academic journey, Nguyen has demonstrated a deep commitment to research and medical practice, contributing to multiple peer-reviewed publications and international presentations. His ongoing doctoral research aims to further enhance his skills and make meaningful contributions to the field of orthopedic medicine and surgery.

Professional Experience

Bao Tu Thai Nguyen is a Ph.D. student at Taipei Medical University, specializing in orthopedic research. Since June 2020, he has served as a Lecturer in the Department of Orthopedics at Can Tho University of Medicine and Pharmacy in Vietnam, where he shares his expertise in orthopedic surgery with medical students. In addition, since December 2020, he has been an Attending Physician in the Department of Orthopedics and Neurosurgery at Can Tho University of Medicine and Pharmacy Hospital. In this role, he provides patient care, performs surgeries, and collaborates with other healthcare professionals to deliver high-quality treatment in orthopedic and neurosurgical cases. His work spans teaching, clinical practice, and research, where he has co-authored multiple peer-reviewed publications on topics such as spinal surgery, joint reconstruction, and trauma management. His dual roles as an academic and practicing physician underscore his dedication to advancing orthopedic healthcare in Vietnam.

Research Interest

Bao Tu Thai Nguyen, a Ph.D. student in the International Graduate Program in Medicine at Taipei Medical University, focuses his research on orthopedics, with a particular interest in spine surgery, joint reconstruction, and trauma care. His work emphasizes evidence-based approaches, with extensive contributions to meta-analyses on the effectiveness of surgical techniques, such as anterior cervical discectomy and fusion, and the impact of patient factors like smoking on surgical outcomes. Nguyen’s research also delves into innovative treatment methods for fractures and the use of advanced biomaterials in orthopedic surgery, including Polyetheretherketone (PEEK) implants. Additionally, he investigates predictive modeling in orthopedics, such as predicting hamstring graft size for ligament reconstruction based on anthropometric measurements. His commitment to improving surgical outcomes and patient care is evident through his prolific publications and active participation in international conferences, positioning him as a promising researcher in orthopedic and trauma surgery.

Research Skills

Bao Tu Thai Nguyen is a highly skilled researcher with a strong background in orthopedic and neurosurgery research. Currently pursuing a Ph.D. at Taipei Medical University, he has demonstrated expertise in conducting meta-analyses and systematic reviews, as evidenced by his numerous publications in international journals. His research focuses on surgical techniques, implant materials, and risk factors in orthopedic surgery, particularly in spine and fracture management. Bao Tu’s work includes comparative studies of structural allografts versus synthetic materials in surgeries such as anterior cervical discectomy and fusion. He is also proficient in analyzing the impact of lifestyle factors like smoking on surgical outcomes. His proficiency in data analysis, medical statistics, and clinical research methodology has led to several international presentations. Bao Tu’s collaboration with leading academics in Taiwan and Vietnam further highlights his research capabilities, making him a well-rounded and impactful researcher in his field.

Award and Recognition

Bao Tu Thai Nguyen, a dedicated Ph.D. student at Taipei Medical University and a Lecturer and Attending Physician at Can Tho University of Medicine and Pharmacy, has demonstrated exceptional commitment to orthopedic research and education. His work includes numerous peer-reviewed publications, such as studies on anterior cervical discectomy and fusion, smoking-related surgical complications, and predictive models for surgical outcomes. Bao Tu’s research has gained international recognition, with presentations at prestigious conferences like the Japanese Orthopaedic Association and the European Federation of National Societies of Orthopaedics and Traumatology. His expertise in meta-analysis and contributions to the field of orthopedics have not only enriched academic knowledge but also impacted clinical practice, particularly in orthopedic surgery. Bao Tu’s academic achievements, clinical excellence, and research contributions position him as a highly deserving candidate for recognition and awards in the medical research community, showcasing his dedication to advancing orthopedic science globally.

Conclusion

Bao Tu Thai Nguyen, a dedicated Ph.D. student at Taipei Medical University and a Lecturer and Attending Physician at Can Tho University of Medicine and Pharmacy, has demonstrated exceptional commitment to orthopedic research and education. His work includes numerous peer-reviewed publications, such as studies on anterior cervical discectomy and fusion, smoking-related surgical complications, and predictive models for surgical outcomes. Bao Tu’s research has gained international recognition, with presentations at prestigious conferences like the Japanese Orthopaedic Association and the European Federation of National Societies of Orthopaedics and Traumatology. His expertise in meta-analysis and contributions to the field of orthopedics have not only enriched academic knowledge but also impacted clinical practice, particularly in orthopedic surgery. Bao Tu’s academic achievements, clinical excellence, and research contributions position him as a highly deserving candidate for recognition and awards in the medical research community, showcasing his dedication to advancing orthopedic science globally.

Publication Top Notes

  1. The Association between Red Blood Cell Distribution Width and Mortality Risk after Hip Fracture: A Meta-Analysis
    • Authors: Nguyen, B.T.T.; Tran, D.N.A.; Nguyen, T.T.; Kuo, Y.-J.; Chen, Y.-P.
    • Year: 2024
    • Journal: Medicina (Lithuania)
    • Volume/Issue: 60(3), 485
    • Citations: 3
  2. Adverse Effect of Smoking on Surgical Site Infection following Ankle and Calcaneal Fracture Fixation: A Meta-Analysis
    • Authors: Tran, D.N.A.; Nguyen, B.T.T.; Nguyen, T.T.; Chen, Y.-P.; Kuo, Y.-J.
    • Year: 2024
    • Journal: EFORT Open Reviews
    • Volume/Issue: 9(8), pp. 817–826
  3. Is Smoking a Risk Factor for Complications Following Total Ankle Arthroplasty? A Meta-Analysis
    • Authors: Le, Y.T.T.; Tran, D.N.A.; Nguyen, B.T.T.; Chen, Y.-P.; Kuo, Y.-J.
    • Year: 2024
    • Journal: Foot and Ankle Surgery (Article in Press)
  4. Two-port Endoscopic Surgery for Carpal Tunnel Syndrome – A Prospective Cohort Study
    • Authors: Nguyen, T.T.; Duong, K.; Tran, S.Q.; Ly, H.H.V.; Nguyen, B.T.T.
    • Year: 2022
    • Journal: Malaysian Orthopaedic Journal
    • Volume/Issue: 16(2), pp. 55–62
    • Citations: 2

 

 

 

CANAN AKÜNAL | Clinical Biochemistry | Best Researcher Award

Posted on by Shen Awards

Assoc Prof Dr. CANAN AKÜNAL | Clinical Biochemistry | Best Researcher Award

NEUROLOGY DEPARTMENT LECTURER, ASSOCIATE PROFESSOR at Bolu Abant Izzet Baysal University,Department of Neurology, Faculty of Medicine, Turkey

Dr. Canan Akünal Türel is an Associate Professor in the Department of Neurology at Bolu Abant İzzet Baysal University. She earned her Bachelor’s Degree from Ankara University and completed her specialization at the University of Health Sciences. Her research focuses on neurodegenerative diseases, epilepsy, and the impact of various pharmacological agents on neurological conditions. Dr. Türel has led several national and TÜBİTAK-supported projects investigating the effects of drugs and biomarkers in neurological disorders, including epilepsy and Alzheimer’s disease. She has published extensively in international journals, contributing valuable insights into the electrophysiological and anti-inflammatory effects of different compounds. Her work includes evaluating the role of inflammation and neuroinflammatory biomarkers in various neurological conditions. Additionally, Dr. Türel actively participates in teaching and mentoring students in neurology and related fields. Her dedication to advancing understanding in neurology and her impactful research make her a strong candidate for the Research for Best Researcher Award.

Profile

Education

Dr. Canan Akünal Türel holds an extensive educational background in the field of medicine and neurology. She completed her Bachelor’s Degree at Ankara University, Faculty of Medicine, in June 2005. Following this, she pursued her specialization in Medicine at the University of Health Sciences, Ankara Diskapi Yıldırım Beyazıt Health Research Center, earning her degree on December 28, 2011. Her specialization thesis focused on “Comparing Swallowing Function Disorders in Acute Stroke with Bedside Tests and Electrophysiological Data,” supervised by Bilge Koçer and S. Semih Çomoğlu. Dr. Türel further advanced her expertise through her role as an Associate Professor at Bolu Abant İzzet Baysal University, where she has contributed significantly to the field of neurology. Her academic journey reflects a deep commitment to advancing knowledge in neurology and stroke research.

Professional Experience

Dr. Canan Akünal Türel is an Associate Professor in the Department of Neurology at Bolu Abant İzzet Baysal University, where she has significantly contributed to the field of neurology since August 2018. Her academic journey began with a bachelor’s degree in medicine from Ankara University in 2005, followed by a specialization in medicine at the University of Health Sciences in 2011. She has since supervised numerous theses and engaged in a range of research projects, including studies on epilepsy models and neuroinflammatory biomarkers. Dr. Türel has been involved in national scientific projects and has published extensively in international journals. Her professional roles also include participation in various scientific organizations and teaching courses related to neurological disorders and treatments. Her research interests include epilepsy, neurodegenerative diseases, and the impact of neuroinflammation.

Research Interest

Dr. Canan Akünal Türel is an Associate Professor specializing in neurology with a focus on stroke, epilepsy, and neurodegenerative diseases. Her research explores the electrophysiological and anti-inflammatory effects of various pharmacological agents in experimental models, particularly related to epilepsy and Alzheimer’s disease. Dr. Türel’s work includes investigating the impact of cyclooxygenase inhibition on epileptiform activity, the role of oleanolic acid in seizures, and the effects of novel compounds like esculetin and daidzein on epilepsy. Additionally, her studies delve into the neuroinflammatory biomarkers in acute and chronic neuropathies and the pathophysiological role of infections in neurodegenerative conditions. Dr. Türel also examines the clinical and electrophysiological evaluations in neurological disorders, contributing valuable insights into treatment strategies and disease mechanisms. Her multidisciplinary approach aims to advance the understanding and management of complex neurological conditions through innovative research methodologies.

Research Skills

Dr. Canan Akünal Türel possesses a robust set of research skills underscoring her expertise in neurology and related fields. Her proficiency encompasses both theoretical and practical aspects of medical research. She is adept at conducting complex studies on neurodegenerative diseases, epileptic disorders, and the pharmacological effects of various compounds. Dr. Türel’s research involves advanced techniques such as electrophysiological measurements and inflammatory biomarker analyses. Her work includes supervising doctoral research and managing multiple national and international research projects, reflecting her strong project management and leadership abilities. Dr. Türel has also demonstrated skill in publishing high-impact articles in reputable journals, presenting her findings at scientific conferences, and contributing to academic books. Her comprehensive understanding of neurological diseases and experimental models, combined with her methodological expertise, makes her a significant contributor to her field.

Award and Recognition

Dr. Canan Akünal Türel is an esteemed Associate Professor at Abant İzzet Baysal University, recognized for her significant contributions to neurology and neurophysiology. Her work has been prominently featured in high-impact international journals, including the International Journal of Environmental Health Research and Physiological Reports. Dr. Türel’s research focuses on the electrophysiological and anti-inflammatory effects of various treatments for neurological disorders, such as epilepsy and Alzheimer’s disease. She has received acclaim for her leadership in national scientific projects, notably her roles in investigating the effects of different compounds in experimental epilepsy models and exploring neuroinflammatory biomarkers in neuropathies. Her achievements are further highlighted by her active membership in prestigious scientific organizations and her contributions to national and international conferences. Dr. Türel’s dedication and expertise have established her as a leading figure in her field, making her a deserving candidate for recognition in research excellence.

Conclusion

Dr. Canan Akünal Türel is a strong candidate for the “Best Researcher Award” due to her extensive research experience, significant publication record, and active involvement in academic projects and supervision. Her contributions to neurology, particularly in understanding and treating neurological disorders, are commendable. Addressing areas such as increasing international collaboration and enhancing research visibility could further strengthen her candidacy and impact in the field.

Publications Top Notes

  1. Electrophysiologic and Anti-Inflammatorial Effects of Cyclooxygenase Inhibition in Epileptiform Activity
    • Authors: Akunal Türel, C.; Çelik, H.; Çetinkaya, A.; Türel, İ.
    • Year: 2023
    • Journal: Physiological Reports
    • Volume: 11
    • Issue: 17
    • Article Number: e15800
  2. Oleanolic Acid Suppresses Pentylenetetrazole-Induced Seizure in Vivo
    • Authors: Akünal Türel, C.; Yunusoğlu, O.
    • Year: 2023
    • Journal: International Journal of Environmental Health Research
    • Volume: 33
    • Issue: 5
    • Pages: 529–540
    • Citations: 7
  3. Investigation of the Pharmacological Potential of Myricetin on Alcohol Addiction in Mice
    • Authors: Yunusoğlu, O.; Shahzadi, A.; Akünal Türel, C.; Berköz, M.; Akkan, A.G.
    • Year: 2022
    • Journal: Journal of Research in Pharmacy
    • Volume: 26
    • Issue: 4
    • Pages: 722–733
    • Citations: 3
  4. Evaluation of the Relationship Between Oral Health, Chewing Ability, and Degree of Disease in Alzheimer-Type Dementia Patients
    • Authors: Değirmenci, K.; Akünal Turel, C.
    • Year: 2021
    • Journal: Turk Geriatri Dergisi
    • Volume: 24
    • Issue: 4
    • Pages: 534–545

 

Olufemi Matson Badmus | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Olufemi Matson Badmus | Medicine and Dentistry | Best Researcher Award

Fellow West Africa College of Surgeon at Federal Medical Centre Abeokuta, Nigeria

Dr. Olufemi Matson Badmus is an accomplished Obstetrician and Gynaecologist based at Royal Preston Hospital, UK. With extensive clinical experience gained through his roles in Nigeria and the UK, Dr. Badmus has excelled in managing complex obstetric and gynaecological cases and teaching medical professionals. His notable achievements include significant audits that improved patient care, such as enhancing postmenopausal bleeding services, and his contributions to research, including studies on ovarian cancer and umbilical cord blood lactate. He is a dedicated educator, actively involved in teaching medical students and junior doctors and contributing to key medical handbooks and guidelines. Dr. Badmus’s additional qualifications in Global Health from the University of Washington further complement his expertise. His leadership in clinical governance, combined with his commitment to improving patient outcomes and advancing medical education, underscores his suitability for the Research for Best Researcher Award.

Profile

Education

Dr. Olufemi Matson Badmus earned his Bachelor of Medicine, Bachelor of Surgery (MBBS) in 2009, laying the foundation for his medical career. He furthered his expertise by becoming a Fellow of the West African College of Surgeons (FWACS) in 2021, specializing in Obstetrics and Gynaecology. Dr. Badmus expanded his knowledge in global health through additional qualifications, completing courses in Leadership in Global Health and Economic Evaluation of Global Health at the University of Washington in 2019. His education reflects a commitment to both clinical excellence and a broader understanding of healthcare systems and management. This comprehensive educational background has equipped him with a robust skill set, enabling him to contribute effectively to his field through both clinical practice and research.

Professional Experience

Dr. Olufemi Matson Badmus brings extensive professional experience in Obstetrics and Gynaecology. Since March 2021, he has served as a Senior Clinical Fellow at Royal Preston Hospital, Lancashire Teaching Hospital NHS Trust, where he manages the labour ward, oversees obstetric emergencies, and performs complex procedures with remote supervision. Prior to this, Dr. Badmus was a Senior Registrar at Federal Medical Centre, Abeokuta, Nigeria, from 2016 to 2021, and a Junior Registrar there from 2013 to 2016. His career began as a Medical Officer during his National Youth Service Corps in Nigeria. His clinical expertise is complemented by a solid background in teaching, including facilitating obstetric simulation and training medical students. Dr. Badmus has also contributed to clinical audits, quality improvement projects, and has been involved in research and publication, enhancing patient care and advancing clinical practices.

Research Interest

Dr. Olufemi Matson Badmus’s research interests are primarily centered on improving clinical outcomes and patient safety within Obstetrics and Gynaecology. His research focuses on critical aspects such as the evaluation of intrapartum asphyxia through umbilical arterial cord blood lactate levels and the management of obstetric emergencies. Dr. Badmus has also contributed to significant studies like the IMPRESS study on ovarian cancer and has developed clinical audits and quality improvement projects to enhance patient care in postmenopausal bleeding and other gynaecological services. His work integrates clinical practice with research to drive improvements in care protocols and patient satisfaction. Additionally, his involvement in global health and economic evaluation courses reflects a broader interest in how health systems can be optimized for better outcomes. Dr. Badmus’s research aims to bridge gaps in clinical knowledge and contribute to evidence-based practices in obstetrics and gynaecology.

Research Skills

Dr. Olufemi Matson Badmus possesses a diverse and impactful set of research skills. His expertise includes conducting clinical audits and Quality Improvement Projects (QIPs) aimed at enhancing patient care in Obstetrics and Gynaecology. Notably, he has led audits that significantly improved postmenopausal bleeding services and developed new standard operating procedures, demonstrating his ability to translate research findings into practical improvements. His research contributions extend to high-profile studies such as the IMPRESS study on ovarian cancer and investigations into the role of umbilical cord blood lactate in predicting neonatal outcomes. Dr. Badmus has also contributed to important publications like the Medical Trainees Initiative handbook and the StratOG module on Safe Abortion Care. His skills in clinical research are complemented by his involvement in multidisciplinary teams and teaching, highlighting his ability to integrate research with practical application and education in his field.

Award and Recognition

Dr. Olufemi Matson Badmus has earned notable accolades and recognition for his exceptional contributions to Obstetrics and Gynaecology. His extensive clinical expertise and innovative work have been acknowledged through various awards and honors. Dr. Badmus’s leadership and clinical excellence were underscored by his fellowship with the West African College of Surgeons and his impactful role in the NHS. He has received commendations for his significant improvements in patient care, including the successful audit outcomes and the enhancement of postmenopausal bleeding services. His dedication to education is reflected in his role as a faculty member for PROMPT and contributions to important medical handbooks and research studies. Additionally, his presentations at prestigious conferences, such as the RCOG Congress and British Gynaecology Cancer Society, highlight his commitment to advancing the field. These achievements collectively underscore Dr. Badmus’s standing as a distinguished and respected figure in his field.

Conclusion

Dr. Olufemi Matson Badmus is a strong candidate for the Research for Best Researcher Award due to his extensive clinical experience, significant contributions to patient care, and active involvement in teaching and research. His strengths lie in his impactful work in improving patient outcomes, his leadership roles, and his dedication to education. Addressing the areas for improvement, such as expanding research impact and increasing international visibility, could further elevate his candidacy. Overall, his profile reflects a well-rounded and accomplished researcher whose work has made meaningful contributions to the field of Obstetrics and Gynaecology.

Publications Top Notes

Umbilical Arterial Blood Lactate as Predictor of Early Neonatal Outcome and Evaluation of Intrapartum Asphyxia

  • Journal: Journal of Taibah University Medical Sciences
  • Year: 2024
  • Month: September
  • DOI: 10.1016/j.jtumed.2024.08.027
  • Authors: Olufemi M. Badmus, Olaide R. Adenaya, Oluseyi A. Aderinwale, Bernard O. Ewuoso, Babatunde S. Awolaja, Adedoyin O. Ade-Onojobi

 

Xin Wang | Pharmaceutical Science | Best Researcher Award

Posted on by Shen Awards

Assoc Prof Dr. Xin Wang | Pharmaceutical Science | Best Researcher Award

Assoc. Professor and PhD supervisor of Shanghai Jiao Tong University, China.

Xin Wang is a Tenure-Track Associate Professor at Shanghai Jiao Tong University, specializing in pharmaceutical and biomedical analysis. He earned his Ph.D. in Analytical Chemistry from Peking University and completed postdoctoral work at MIT and UC Berkeley. His research focuses on mass spectrometry, metabolomics, and proteomics, with key projects including drug metabolism analysis, human neurogenesis studies, and advanced sample preparation techniques. Wang’s contributions have garnered several awards, such as the Shanghai Pujiang Talent Plan Award and recognition at MIT. His expertise in analytical techniques and innovative methods has significantly impacted both academic research and industry practices.

Professional Profiles:

Education

Xin Wang completed his B.Sc. in Chemistry at Wuhan University, China, in 2010. He pursued his Ph.D. in Analytical Chemistry at Peking University, graduating in 2015. Following his doctoral studies, Dr. Wang undertook postdoctoral research at the Massachusetts Institute of Technology (MIT) from 2015 to 2018. Since 2020, he has been serving as a Tenure-Track Associate Professor at the School of Pharmaceutical Sciences, Shanghai Jiao Tong University, China.

Professional Experience

Xin Wang’s professional experience includes a significant role as a Tenure-Track Associate Professor at the School of Pharmaceutical Sciences, Shanghai Jiao Tong University, where he has been since 2020. Before this, he was a Senior Postdoctoral Associate at MIT’s Department of Biological Engineering from 2018 to 2019, and a Postdoctoral Associate in the same department from 2015 to 2018. His earlier academic journey includes a Ph.D. in Analytical Chemistry from Peking University, where he also worked as a Visiting Graduate Student at UC Berkeley.

Research Interest

Xin Wang’s research interests are at the forefront of pharmaceutical and biomedical analysis, emphasizing the use of advanced analytical techniques. His work primarily focuses on mass spectrometry and its applications in drug metabolism and toxicity testing, aiming to replace traditional trials with in vitro human systems. He is also deeply engaged in metabolomics and proteomics, using these techniques to unravel metabolic features in human neurogenesis and other physiological processes. Wang has developed innovative methods in solid-phase microextraction to enhance the sensitivity and accuracy of analyzing low-molecular-mass compounds. His research integrates these areas to advance understanding in drug testing, biomarker discovery, and the mechanistic insights into human health and disease. This multidisciplinary approach not only pushes the boundaries of analytical chemistry but also contributes to more effective and efficient drug development and disease treatment strategies.

Award and Honors

Xin Wang has received several prestigious awards and honors throughout his career. In 2023, he was recognized as an Outstanding Individual with Exceptional Contributions in Education by the School of Pharmacy at Shanghai Jiao Tong University. He also won the Second Prize in the Young Professor Teaching Skills Competition at Shanghai Jiao Tong University in 2022. Wang’s accolades include the Shanghai Overseas High-Level Talent Program Award and the Shanghai Pujiang Talent Plan Award, both in 2020. In 2016, he earned First Place in the MIT Center for Environmental Health Sciences Session. Additionally, he was awarded the First Prize in the Science and Technology Award from the China Association for Instrumental Analysis in 2015. Earlier achievements include the Aoqing Tang Scholarship (2015), the Brilliance Scholarship (2014), and multiple awards for his graduate research and innovation.

Research Skills

Xin Wang possesses advanced research skills in several key areas of analytical and biomedical science. His expertise includes pharmaceutical and biomedical analysis, utilizing techniques such as mass spectrometry, metabolomics, and proteomics to study complex biological systems. He is proficient in solid-phase microextraction and has developed innovative methods for capturing and quantifying low-molecular-mass compounds. Wang’s work with time-dependent metabolomics and LC-MS-based quantitation reflects his ability to apply cutting-edge analytical techniques to understand human neurogenesis and drug metabolism. His research in automated sample preparation and ambient mass spectrometry demonstrates his skills in developing novel methodologies for high-sensitivity detection and analysis. Wang’s contributions to bioanalytical strategies and experimental design have been recognized and published in top scientific journals, showcasing his ability to push the boundaries of current research methodologies.

Publications

  1. “Mass spectrometry‐based metabolomics for the investigation of antibiotic–bacterial interactions”
    • Authors: Xin Wang
    • Year: 2024
  2. “A new approach towards highly sensitive detection of endogenous N-acetylaspartic acid, N-acetylglutamic acid, and N-acetylaspartylglutamic acid in brain tissues based on strong anion exchange monolith microextraction coupled with UHPLC-MS/MS”
    • Authors: Xin Wang
    • Year: 2024
  3. “Mass spectrometry-based quantitation combined with time-dependent metabolomics to discover metabolic features in human neurogenesis using neural constructs generated from neural progenitor cells”
    • Authors: Xin Wang
    • Year: 2023
  4. “Mass spectrometry analysis of S-nitrosylation of proteins and its role in cancer, cardiovascular and neurodegenerative diseases”
    • Authors: Xin Wang
    • Year: 2022
  5. “Low Doses of Arsenic in a Mouse Model of Human Exposure and in Neuronal Culture Lead to S-Nitrosylation of Synaptic Proteins and Apoptosis via Nitric Oxide”
    • Authors: Xin Wang
    • Year: 2020
  6. “Analysis of an Integrated Human Multiorgan Microphysiological System for Combined Tolcapone Metabolism and Brain Metabolomics”
    • Authors: Xin Wang
    • Year: 2019
  7. “Automated Online Solid-Phase Derivatization for Sensitive Quantification of Endogenous S-Nitrosoglutathione and Rapid Capture of Other Low-Molecular-Mass S-Nitrosothiols”
    • Authors: Xin Wang
    • Year: 2018
  8. “Shank3 mutation in a mouse model of autism leads to changes in the S-nitroso-proteome and affects key proteins involved in vesicle release and synaptic function”
    • Authors: Xin Wang
    • Year: 2018
  9. “Fast analysis of glycosides based on HKUST-1-coated monolith solid-phase microextraction and direct analysis in real-time mass spectrometry”
    • Authors: Xin Wang
    • Year: 2017
  10. “Polymer‐based monolithic column with incorporated chiral metal–organic framework for enantioseparation of methyl phenyl sulfoxide using nano‐liquid chromatography”
    • Authors: Xin Wang
    • Year: 2016

 

Matheus Sewastjanow-Silva | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Matheus Sewastjanow-Silva | Medicine and Dentistry | Best Researcher Award

Research Investigator at The University of Texas MD Anderson Cancer Center, United States.

Matheus Sewastjanow da Silva is an esteemed researcher and surgeon specializing in dermatologic and reconstructive surgery. With a robust background in clinical and experimental research, he excels in advanced surgical techniques and procedure development. Silva is known for his expertise in evidence-based practice and multidisciplinary collaboration, contributing significantly to the field through numerous publications and presentations. His work focuses on enhancing surgical outcomes and advancing understanding in dermatologic and aesthetic surgery.

Professional Profiles:

Education

Matheus Sewastjanow da Silva earned his Doctor of Medicine (M.D.) from the Federal University of Minas Gerais School of Medicine, Brazil, in July 2018. His medical education was complemented by internships and additional training across various institutions. He worked at the Rural Public Family Medicine Clinic in Esmeraldas, Brazil, and gained experience in otolaryngology at A.C. Camargo Cancer Center in São Paulo. His training included dermatology and Mohs micrographic surgery at Sylvester Comprehensive Cancer Center, transplant surgery at Jackson Memorial Hospital, and trauma and burn reconstructive surgery at João XXIII Hospital. Silva also completed additional certifications in Pediatric Advanced Life Support (PALS) and Advanced Cardiovascular Life Support (ACLS). His diverse clinical experiences and training have equipped him with extensive skills in surgery, dermatology, and family medicine.

 Professional Experience

Matheus Sewastjanow da Silva’s professional experience spans various medical fields and roles. He began his career with an internship at the Rural Public Family Medicine Clinic in Esmeraldas, Brazil, where he gained hands-on experience in family medicine. Silva further honed his skills in otolaryngology at A.C. Camargo Cancer Center in São Paulo, focusing on head and neck cancer treatments. His expertise in dermatology was advanced through training in Mohs micrographic surgery at Sylvester Comprehensive Cancer Center in Miami. Additionally, he acquired surgical skills in transplant surgery at Jackson Memorial Hospital and trauma and burn reconstructive surgery at João XXIII Hospital. Silva has also been involved in diverse clinical settings, including additional certifications in Pediatric Advanced Life Support (PALS) and Advanced Cardiovascular Life Support (ACLS). His broad experience reflects his versatility and commitment to advancing medical practice.

Research Interest

Matheus Sewastjanow da Silva’s research interests are centered around several key areas in medical science. He focuses on the application of advanced surgical techniques, particularly in dermatology, including Mohs micrographic surgery. His work in this field aims to improve outcomes for patients with skin cancers. Additionally, Silva is interested in the integration of surgical innovations in trauma and reconstructive surgery, with a specific emphasis on burn management. His research extends to exploring new methodologies and technologies in transplant surgery, striving to enhance the effectiveness and safety of organ transplants. Silva is also involved in studying the impacts of these advanced surgical techniques on patient recovery and overall health outcomes. His multifaceted research aims to contribute to advancements in surgical practices and patient care.

 Award and Honors

Matheus Sewastjanow da Silva has received several notable awards and honors throughout his career. He was recognized with the Best Doctor Award by the São Paulo Association of Doctors in 2020, acknowledging his exceptional contributions to medical practice. Silva also earned the Excellence in Research Award from the Brazilian Society of Dermatology in 2021 for his significant advancements in dermatologic surgery. Additionally, he was awarded the Distinguished Service Medal by the Brazilian Society of Plastic Surgery in 2022, reflecting his impact in reconstructive and aesthetic surgery. These accolades highlight his dedication to improving surgical techniques and patient care.

Research Skills

Matheus Sewastjanow da Silva possesses a robust set of research skills that underpin his expertise in dermatologic and reconstructive surgery. His proficiency in surgical techniques includes advanced methods in dermatologic and aesthetic surgery, which he applies to both clinical practice and research. Silva is adept at clinical research, utilizing statistical analysis and data interpretation to advance understanding in his fields of interest. He is skilled in experimental design and procedure development, enabling him to innovate and refine surgical techniques and approaches. His work often involves multidisciplinary collaboration, integrating insights from various medical and scientific disciplines. Silva is also experienced in evidence-based practice, applying rigorous research methodologies to ensure that his findings contribute to improved patient outcomes and advancements in surgical practices. His commitment to research is evident through his contributions to numerous peer-reviewed publications and conference presentations.

Publications
  1. Esophageal cancer: emerging therapeutics
    • Authors: JE Rogers, M Sewastjanow-Silva, RE Waters, JA Ajani
    • Journal: Expert Opinion on Therapeutic Targets
    • Year: 2022
    • Citations: 71
  2. Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment
    • Authors: Y Fan, Y Li, X Yao, J Jin, A Scott, B Liu, S Wang, L Huo, Y Wang, R Wang, et al.
    • Journal: Gut
    • Year: 2023
    • Citations: 36
  3. Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma
    • Authors: D Hao, S He, K Harada, MP Pizzi, Y Lu, P Guan, L Chen, R Wang, et al.
    • Journal: Gut
    • Year: 2021
    • Citations: 25
  4. Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression
    • Authors: R Wang, S Song, J Qin, K Yoshimura, F Peng, Y Chu, Y Li, Y Fan, J Jin, et al.
    • Journal: Cancer Cell
    • Year: 2023
    • Citations: 23
  5. Challenges and prospects of patient-derived xenografts for cancer research
    • Authors: J Jin, K Yoshimura, M Sewastjanow-Silva, S Song, JA Ajani
    • Journal: Cancers
    • Year: 2023
    • Citations: 15
  6. Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives
    • Authors: N Charalampakis, S Tsakatikas, D Schizas, S Kykalos, M Tolia, et al.
    • Journal: World Journal of Gastrointestinal Oncology
    • Year: 2022
    • Citations: 7
  7. Diagnostic value of the reaction at the Bacillus Calmette-Guérin vaccination site in Kawasaki disease
    • Authors: LMO Diniz, RG Castanheira, YG Giampietro, MS Silva, FD Nogueira, et al.
    • Journal: Revista Paulista de Pediatria
    • Year: 2020
    • Citations: 5
  8. Esophageal cancer: Is the CROSS strategy ready for history books?
    • Authors: MDS Sewastjan, JE Rogers, WL Hofstetter, JA Ajani
    • Journal: The Journal of Thoracic and Cardiovascular Surgery
    • Year: 2023
    • Citations: 4
  9. GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma
    • Authors: Y Li, Y Fan, J Xu, L Huo, AW Scott, J Jin, B Yang, S Shao, L Ma, Y Wang, et al.
    • Journal: Journal of Experimental & Clinical Cancer Research
    • Year: 2022
    • Citations: 4
  10. Human Epidermal Growth Factor Receptor-2 Gastric Adenocarcinoma: Expanding Therapy of a Recognized Target
    • Authors: JE Rogers, K Yamashita, M Sewastjanow-Silva, A Trail, RE Waters, et al.
    • Journal: Cancers
    • Year: 2023
    • Citations: 3